Login / Signup
Risankizumab versus ustekinumab for moderate-to-severe plaque psoriasis.
Massimo Fioranelli
Maria Grazia Roccia
Torello Lotti
Published in:
Dermatologic therapy (2017)
Keyphrases
</>
coronary artery disease
high intensity
early onset
atopic dermatitis
drug induced